Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
The RMR Group
RMR
$323M
| $3.09M | ﹤0.01% |
109,400
+2,319
| +2% | +$63.1K |
|
2427
OneSpan
OSPN
$587M
| $3.08M | ﹤0.01% |
275,261
+9,323
| +4% | +$107K |
|
2428
Kiniksa Pharmaceuticals
KNSA
$5.73B
| $3.08M | ﹤0.01% |
205,557
+1,057
| +0.5% | +$15.4K |
|
2429
BioXcel Therapeutics
BTAI
$26M
| $3.08M | ﹤0.01% |
8,955
+174
| +2% | +$42.1K |
|
|
DQ
2430
Daqo New Energy
DQ
$926M
| $3.07M | ﹤0.01% |
79,539
+2,078
| +3% | +$102K |
|
2431
WIX.com
WIX
$2.4B
| $3.05M | ﹤0.01% |
39,670
-366
| -0.9% | -$29.6K |
|
2432
AvePoint
AVPT
$2.84B
| $3.04M | ﹤0.01% |
739,929
+22,880
| +3% | +$97.9K |
|
2433
Vital Farms
VITL
$551M
| $3.04M | ﹤0.01% |
203,711
+2,994
| +1% | +$41.3K |
|
2434
Arcturus Therapeutics
ARCT
$170M
| $3.03M | ﹤0.01% |
178,551
+7,727
| +5% | +$135K |
|
|
TSVT
2435
DELISTED
2seventy bio
TSVT
| $3.01M | ﹤0.01% |
321,579
+6,868
| +2% | +$96.9K |
|
2436
Forrester Research
FORR
$224M
| $3.01M | ﹤0.01% |
84,184
+3,074
| +4% | +$112K |
|
|
INST
2437
DELISTED
Instructure Holdings, Inc.
INST
| $3M | ﹤0.01% |
127,899
+3,473
| +3% | +$81.1K |
|
2438
Metropolitan Bank Holding Corp
MCB
$1.16B
| $3M | ﹤0.01% |
51,097
+302
| +0.6% | +$19.1K |
|
2439
Viridian Therapeutics
VRDN
$2.1B
| $2.99M | ﹤0.01% |
102,240
+28,691
| +39% | +$661K |
|
2440
Babcock & Wilcox
BW
$1.42B
| $2.98M | ﹤0.01% |
516,838
+12,755
| +3% | +$69.7K |
|
2441
MetroCity Bankshares
MCBS
$1.02B
| $2.96M | ﹤0.01% |
136,668
+1,932
| +1% | +$42K |
|
2442
Rush Enterprises Class B
RUSHB
$6.16B
| $2.95M | ﹤0.01% |
78,552
-408
| -0.5% | -$14.4K |
|
2443
Codexis
CDXS
$159M
| $2.93M | ﹤0.01% |
628,381
+15,713
| +3% | +$86.1K |
|
2444
Inovio Pharmaceuticals
INO
$57.6M
| $2.92M | ﹤0.01% |
155,883
+4,390
| +3% | +$99.5K |
|
2445
Dole
DOLE
$1.35B
| $2.9M | ﹤0.01% |
300,127
+77,264
| +35% | +$704K |
|
2446
Custom Truck One Source
CTOS
$2.43B
| $2.89M | ﹤0.01% |
457,690
+13,661
| +3% | +$88.6K |
|
|
CYBR
2447
DELISTED
CyberArk
CYBR
| $2.89M | ﹤0.01% |
22,305
+79
| +0.4% | +$11.4K |
|
2448
IES Holdings
IESC
$14.3B
| $2.89M | ﹤0.01% |
81,238
+1,771
| +2% | +$57.4K |
|
|
FLIC
2449
DELISTED
First of Long Island Corp
FLIC
| $2.89M | ﹤0.01% |
160,345
+2,264
| +1% | +$41.1K |
|
2450
Microvision
MVIS
$91.3M
| $2.88M | ﹤0.01% |
81,804
+1,806
| +2% | +$84K |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.